NewMarket shorts jump 13% in a week ahead of Q3 print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
NewMarket Corporation reports Q3 results today with short sellers notably more active than they were a week ago, even as the borrow market remains comfortably loose.
The sharpest move heading into the print is in short interest. Shares short climbed roughly 13% over the past week to 5.7% of the free float, reversing a month-long decline that had taken the position down more than 6%. The jump is recent and concentrated: the bulk of the build arrived between October 23 and October 26, when short shares surged from around 440,000 to 537,000. Despite that, borrow conditions offer no squeeze pressure. Availability is running above 1,000%, meaning roughly ten shares are available to lend for every one already borrowed. Cost to borrow is at 0.42%, eased about 7% over the week. The lending market is not concerned. Options positioning adds a mild layer of caution: the put/call ratio is at 0.83, just above its 20-day average of 0.82, a marginally more defensive tilt than usual but well within normal range and far below the 52-week high of 0.87.
The analyst picture is effectively absent. The most recent coverage change on record dates to 2019, and the mean price target of $651 is stale enough to be unusable against a stock trading near $873. That leaves the debate almost entirely in the hands of the tape and the fundamental story. The bull case rests on NewMarket's position as a near-oligopoly supplier of petroleum additive chemistry, a business with sticky customer relationships and pricing that has supported steady free cash flow. The bear case centres on demand cyclicality: lubricant additive volumes track vehicle miles driven and industrial output, both of which face headwinds from a softer global manufacturing backdrop. The stock is down roughly 3% over the past month and 1.3% on the week, modestly underperforming specialty chemicals peers. Eastman Chemical gained 5% on the week, and Avient rose nearly 4%, making NEU's drift look comparatively soft.
Ownership adds one genuinely notable detail. Bruce Gottwald filed a Schedule 13D/A in January 2026, putting his stake at 10.1% of the class. A 13D filing carries activist intent on its face. His institutional holding of 926,340 shares makes him the largest reported holder, ahead of BlackRock at 7.6%. Thomas Gottwald, Chairman, President and CEO, gifted 1,711 shares in two transactions across June, but those are compensation-related disposals rather than open-market sales. The family's combined grip on the share count means a relatively thin float, which amplifies the significance of even modest short interest moves. (Schedule 13D/G disclosures are event-driven around the 5% threshold; stakes are as last disclosed and holders dropping below 5% may exit without a further filing.)
The two most recent earnings prints give a useful frame for expected volatility. Following the July 2026 quarter, the stock gained 7.9% on the day and 13.4% over the five sessions that followed. The preceding print produced a 10.7% single-day move and a 12.6% five-day return. Both were strongly positive reactions. Today's print will test whether NewMarket's additive volumes and margins have sustained that momentum through a quarter when its peers have been more mixed, and whether the fresh short-selling of the past week reflects genuine concern about a miss or simply pre-event hedging into a historically reactive name.
Stocks in this article
See the live data behind this article on ORTEX.
Open NEU on ORTEX →How this article was generated
- Generated
- 29 Oct 2026, 04:36
- Data as of
- 29 Oct 2026, 04:09
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.